Objective: To analyze acute splenic sequestration (ASS) in children with sickle cell anemia diagnosed through a newborn screening program in the state of Minas Gerais, Brazil, and followed up at the hematology center in the city of Belo Horizonte, Minas Gerais, Brazil. Results: A total of 89 patients had 173 episodes of ASS (10.2 first episodes per 100 patient-years); 75% of the first episodes occurred before 2 years of age. The estimated probability of occurrence of the first episode of ASS during the study period was 40%. Recurrence rate reached 57.3%. After the first episode, splenectomy was indicated in only 12.4% of the cases; after the second, in 60.4% of the cases. After the third episode, 41.7% of the patients remained under clinical observation. The median time between indication for splenectomy and the actual surgical procedure was 2 months. During the intervening period, 37.2% of the children suffered a new episode of ASS and one child died.
Introduction
Sickle cell disease is a global public health problem. In Brazil, the estimated number of individuals with sickle-cell trait is 7,200,000, with prevalence in the general population between 2 and 8%. 1 In the state of Minas Gerais, southeastern Brazil, the incidence of sickle-cell trait in the newborn statewide screening program (Programa Estadual de Triagem Neonatal, PETN-MG) is 3.3%. 2 Acute splenic sequestration (ASS) refers to a common complication in children with sickle cell anemia. ASS is characterized by the pooling of red cells in the spleen, with a consequent increase in organ size and fall in hemoglobin levels.
ASS is considered an important cause of death in the first decade of life, just second to infectious episodes. [3] [4] [5] [6] [7] The episodes show prevalence of 7.5 to 30%, occurring more frequently between 3 months and 5 years of age (76% before 2 years of age) and in patients with homozygous SS hemoglobinopathy.
The etiology of sequestration crises has yet to be defined.
Blood flow is believed to divert through the intrasplenic shunts, causing growth of the organ, red blood cell retention and capillary engorgement. 4, [8] [9] [10] [11] There is no evidence of a seasonal pattern suggesting an infectious cause. Clinically, the episodes are considered a medical emergency: patients may show signs of hypovolemic shock, progressing to death within a few hours. Effective treatment consists of early diagnosis, clinical support and packed red blood cell transfusion. Some reports demonstrate high recurrence and mortality rates. 4, [6] [7] [8] [12] [13] [14] [15] [16] [17] [18] [19] There is still controversy concerning subsequent management. Options include: careful clinical observation, periodic packed red blood cell transfusion regimens and splenectomy.
Clinical trials on ASS are retrospective, descriptive, noncontrolled and raise questions about the actual splenic function after the episodes, in addition to the pros and cons of splenectomy compared with chronic transfusions. 3, 11, 13, 20, 21 National data on ASS crises are not available in papers Twenty-nine patients were excluded from the study, as follows: other electrophoretic profiles at 6 months of age (2 General mortality rate up to 2 years of age was obtained as a result of the number of deaths up to 2 years of age divided by the exposed population, since all patients had the opportunity to be followed up, at least, until this age.
The Kaplan-Meier method was used to determine the probability curve for occurrence of the first episode of ASS.
The children who died were "censored", if death was not a result of the first episode of ASS, as well as the children who did not have an episode of ASS until the end of the study. Only one child did not receive medical care during ASS.
Patients were assisted mainly in tertiary hospitals in the city of Belo Horizonte or at Hemominas (57.8%); medical care in the countryside was recorded in 26.6%.
Baseline hematologic values as well as during the 173 episodes of ASS are summarized in Table 1 .
Diagnoses associated with ASS were recorded for 91 episodes, infectious diseases being the most common association (89.6%). In 24 episodes, there was no association recorded and, in 58, the information was missing on the medical record.
The choice of management for acute episode was clinical follow-up or indication for splenectomy. None of the children were included in a chronic red blood cell transfusion program. Acute splenic sequestration in sickle cell disease -Rezende PV et al. Table 3 shows associations between ASS and the variables analyzed.
Discussion
In the present study, the incidence of ASS was 10. The probability curve for occurrence of the first episode of ASS ( Figure 1 ) indicates that 27.1, 33 and 37% of the children are likely to have suffered the first episode of ASS at the age of 2, 3 and 5 years, respectively. The Jamaican estimate, 8 using a similar methodology, was 22.5, 26.5 and ASS = acute splenic sequestration. * To calculate numbers after the second episode, children who suffered only one episode of ASS and those who were not submitted to splenectomy after the first episode of AAS, although recommended by the physician, were excluded. The same procedure was adopted to calculate numbers for the remaining episodes. The data presented in Table 2 Patients whose spleens were palpated below the left costal arch during some time of the follow-up presented approximately 2-fold increased risk of an episode of ASS in relation to those without splenomegaly. A similar result was found in Jordan. 14 No statistically significant association was observed between development of ASS and hemoglobin values, platelet count or reticulocyte count (Table 3 ), in accordance with data from the current literature. 8, 14 However, children who did not have ASS showed fetal hemoglobin levels significantly higher than those with ASS. This association has already been described in several studies and is justified by the fact that red blood cells with a greater amount of fetal hemoglobin have lower levels of hemoglobin S, demonstrating less chance of sickling and, consequently, less probability of clinical manifestations. 8, 10, 11, 27, 28 Furthermore, a statistically significant association was observed between lower baseline leukometry and development of ASS. We could not find a similar result in the several articles searched in the current literature. The associations detected, although statistically significant, were weak and cannot accurately predict which child would more likely develop ASS, thus failing to have clinical relevance.
In the present study, general case-fatality of ASS was 5 deaths in 173 episodes of ASS (2.9%), much lower than that reported in the Jamaican cohort (9.8%). 8 However, the number of deaths of unknown cause (4/19 = 21.1%) was significantly high, which could mean underestimation of ASS case-fatality due to lack of recognition of this condition as a cause of death, as demonstrated in a study carried out with children at PETN-MG. 22 The evaluation of the causes of the 19 deaths indicated the infectious processes as the main conditions leading to death (36.8%), followed by ASS (26.3%). Our findings are similar to the data published by some authors. 12, 15, 16, 18, 19, 25 Among national data, the study by Fernandes 22 socioeconomic difficulties, lack of safe and fast transportation of the affected children and lack of resources to immediately perform blood transfusion and basic hematologic tests.
We cannot deny that some important steps to improve this situation have already been taken in several states and, in particular, in the state of Minas Gerais. Newborn screening for sickle cell disease, periodic training of the several health teams, introduction and publishing of specific protocols on the management of acute episodes of the disease, in addition to a multidisciplinary follow-up in specialized institutions and, especially, family education 8, 25, 30 are the hope to overcome difficulties in the short and the medium term.
It is evident that there is no simple solution for this problem, since it is not a simple problem. However, the present study alerts to the long way ahead. The program of total care
to the individual with sickle cell anemia is a goal to be achieved by everyone involved in the problem, including managers, health professionals and family. Issues related to the disease should be recognized as a priority to the appropriate integral care, not of the sickle cell disease itself, but of children with sickle cell disease.
